News
The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...
As part of this initiative, Invest UP — the state’s nodal investment promotion agency — is organising a series of global roadshows and strategic business engagements across the United States, Europe, ...
The global calcium supplements market is on a steady growth trajectory, valued at USD 6.19 billion in 2025 and projected to ...
The global market for vitamin D ingredients is expected to grow at a CAGR of 7.2% between 2025 and 2035, reaching USD 3.2 ...
Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...
Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...
GSK PLC closed 15.86% short of its 52-week high of £16.79, which the company achieved on September 9th.
The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...
Recent health-related developments highlight significant shifts in the pharma industry and governance: France's Carmat files ...
GSK plc (NYSE: GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results